Beam Therapeutics Inc. (BEAM) Free cash flow 2019–2025
Beam Therapeutics Inc. (BEAM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$360.0MFY2025 · since FY2019: -$84.5M → -$360.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$360.0M | -1.1% |
| FY2024 | -$356.2M | -94.7% |
| FY2023 | -$182.9M | -592.3% |
| FY2022 | -$26.4M | +76.6% |
| FY2021 | -$113.1M | -0.9% |
| FY2020 | -$112.1M | -32.6% |
| FY2019 | -$84.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BEAM financial trends
BEAM RevenueBEAM Net incomeBEAM Net marginBEAM Gross profitBEAM Gross marginBEAM Operating incomeBEAM Operating marginBEAM Operating cash flowBEAM Capital expendituresBEAM Return on equityBEAM Stock buybacksBEAM Dividends paidBEAM Total assetsBEAM Total liabilitiesBEAM Shareholders’ equityBEAM overview →